Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
14,965,850
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
2,446,157
-
Shares change
-
-262,184
-
Total reported value, excl. options
-
$5,893,000
-
Value change
-
-$555,959
-
Number of buys
-
2
-
Number of sells
-
-10
-
Price
-
$2.41
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q3 2022
22 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q3 2022.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,446,157 shares
of 14,965,850 outstanding shares and own 16% of the company stock.
Largest 10 shareholders include DIMENSIONAL FUND ADVISORS LP (623,867 shares), RENAISSANCE TECHNOLOGIES LLC (596,863 shares), VANGUARD GROUP INC (374,691 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (286,655 shares), ACADIAN ASSET MANAGEMENT LLC (188,164 shares), BlackRock Inc. (140,350 shares), GEODE CAPITAL MANAGEMENT, LLC (74,718 shares), TWO SIGMA INVESTMENTS, LP (45,215 shares), STATE STREET CORP (43,045 shares), and TWO SIGMA ADVISERS, LP (24,700 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.